Atlas Trials

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Clinical trial NCT05681442 · RECRUITING

Trial details

NCT number
NCT05681442
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Sepsis
Start date
2023-11-13
Primary completion
2027-01-04
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.